Why the study?
Are subcutaneous implantable cardioverter defibrillators (S-ICDs) feasible and safe for patients at risk of sudden cardiac death?
Case Series (n=5)
No
Are subcutaneous implantable cardioverter defibrillators (S-ICDs) feasible and safe for patients at risk of sudden cardiac death?
This case series reports on the initial feasibility and safety of subcutaneous implantable cardioverter defibrillator (S-ICD) implantation in Singapore.
Transvenous implantable cardioverter defibrillators are a type of implantable cardiac device. They are effective at reducing total and arrhythmic mortality in patients at risk of sudden cardiac death. Subcutaneous implantable cardioverter defibrillators (S-ICDs) are a new alternative that avoids the disadvantages of transvenous lead placement. In this case series, we report on the initial feasibility and safety of S-ICD implantation in Singapore.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2015) conducted a case series in Risk of sudden cardiac death (n=5). Subcutaneous implantable cardioverter defibrillator (S-ICD) was evaluated on Acute complications up to two weeks post-discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: